Proactive Investors - Run By Investors For Investors

MGC Pharmaceuticals to reveal medical cannabis agreement

The halt will remain in place until Wednesday 3rd May 2017.
MGC Pharmaceuticals to reveal medical cannabis agreement
MGC has some major news pending

MGC Pharmaceuticals (ASX:MXC) is some interesting news pending with the execution of a material strategic agreement with the Royal Melbourne Institute of Technology (RMIT).

The agreement relates to the company’s Australian based medical cannabis operations, licensing and strategy.

The ASX has granted a trading halt for MGC to prepare.

The halt will remain in place until the opening of trade on Wednesday 3rd May 2017, or earlier if an announcement is made to the market.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MXC profile View Profile

MGC Pharmaceuticals Ltd Timeline

Related Articles

cannabis flower
April 27 2019
The company's footprint continues to grow as it focuses on becoming a globally recognized house of brands with a broad portfolio of clients across North America
A cannabis facility
January 10 2019
The Vancouver-based medicinal cannabis grower’s Queensland facility will be the world's largest greenhouse cannabis operation, covering a 99-acre site
A WeedMD greenhouse
January 22 2019
WeedMD produces cannabis and cannabis oil for both the medical and adult-use markets

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use